Catalyst Wire Dossier Catalyst Wire Dossier

Siremadlin

siremadlin · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Siremadlin, covering 2025-01-14 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. [Phase 1]

See pricing